Save time and get answers to complex questions with AI chat
Mebendazole ingredients?Patent expiration date of guselkumab?Bivalirudin manufacturer?Combivent generic equivalent?Combivent inhaler hfc 152a patents?
See the DrugPatentWatch profile for kesimpta
Kesimpta’s active ingredient is ofatumumab, a monoclonal antibody. Monoclonal antibodies are made from living cells using biotechnology, where the antibody is produced as a protein biologic drug and then formulated for injection.
Kesimpta is a biologic (antibody) therapy, not a traditional small-molecule chemical tablet. That means it is manufactured as a protein drug (ofatumumab) rather than synthesized as a chemical.
People sometimes ask “made from” to mean the additional components in the injection besides the antibody. Those parts are typically formulation ingredients used to stabilize the protein and make the medicine suitable for dosing, but the key medicine itself is ofatumumab (the antibody).
Other Questions About Kesimpta :